CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer

International Journal of Gynecology and Obstetrics

Volumn 94, Issue SUPPL. 1, 2006, Pages

  Bosch, F Xavier ^a   Qiao, You Lin ^a   Castellsagué, Xavier ^a  

^a NONE

Author keywords

Cervical cancer; Epidemiology; Human papillomavirus

Indexed keywords

ORAL CONTRACEPTIVE AGENT; VIRUS DNA;

ADENOCARCINOMA; ARTICLE; CANCER GRADING; CANCER RISK; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; ORAL CONTRACEPTION; PARITY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SMOKING; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 33846584559     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(07)60004-6     Document Type: Article

References (30)

1. Clifford G., Callus S., Herrero R., Munoz N., Snijders P., Vaccarella S., Anh P., Ferreccio C., Hieu N., Matos E., Molano M., Rajkumar R., Ronco G., de Sanjose S., Shin H., Sukvirach S., Thomas J., Tunsakul S., Meijer C., and Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
2. de Sanjose S. Human Papillomavirus and cancer. Epidemiology and prevention. 4th Monograph of the Spanish Society of Epidemiology (2006) 143-147
3. Kjaer S., Chackerian B., van der Brule A., Svare E., Paull G., Walboomers J., Schiller J., Bock J., Sherman M., Lowy D., and Meijer C. High-Risk Human Papillomavirus Is Sexually Transmitted: Evidence from a Follow-up Study of Virgins Starting Sexual Activity (Intercourse). Cancer Epidemiol Biomark Prev 10 (2001) 101-106
4. Castellsague X., Ghaffari A., Daniel R., Bosch F., Munoz N., and Shah K. Prevalence of penile human papillomavirus DMA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 176 (1997) 353-361
5. Bosch F., Castellsague X., Munoz N., de Sanjose S., Ghaffari A., Gonzalez L., Gili M., Izarzugaza I., Viladiu P., Navarro C., Vergara A., Ascunce N., Guerrero E., and Shah K. Male sexual behavior and Human Papillomavirus DMA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 88 15 (1996) 1060-1067
6. Cason J. Perinatal acquisition of cervical cancer-associated papillomaviruses. Br J Obstet Gynaecol 103 (1996) 853-858
7. Bosch F.X., and Iftner T. The aetiology of cervical cancer (2005), NHS Cervical Screening Programme, Sheffield, UK
8. Moscicki A., Hills N., Shiboski S., Powell K., Jay N., Hanson E., Miller S., Clayton L., Farhat S., Broering J., Darragh T., and Palefsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. J Am Med Assoc 285 (2001) 2995-3002
9. Mufioz N., Castellsague X., Bosch F., Tafur L., de Sanjose S., Aristizabal N., Ghaffari A., and Shah K. Difficulty in Elucidating the Male Role in Cervical Cancer in Colombia, a High-Risk Area for the Disease. J Natl Cancer Inst 88 15 (1996) 1068-1075
10. de Sanjose S., Bosch F., Vails I., Canadas M., Castellsague X., Lloveras B., and Shah K. Prevalence of HPV cervical infections among imprisoned women in Barcelona, Spain. Sex Transm Infect 76 (2000) 58
11. Kjaer S., Svare E., Worm A., Walboomers J., Meijer C., and van Den Brule A. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 27 (2000) 438-445
12. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Cervix Cancer Screening (2005), IARC Press, Lyon
13. Franceschi S., Castellsague X., dal Maso L., Smith J., Plummer M., Ngelangel C., Chichareon S., Eluf-Neto J., Shah K., Snijders P., Meijer C., Bosch F., and Munoz N. Prevalence and determinants of human papillomavirus genital infection in men. BrJ Cancer 86 (2002) 705-711
14. Castellsague X., Bosch F., Munoz N., Meijer C., Shah K., de Sanjose S., Eluf-Neto J., Ngelangel C., Chichareon S., Smith J., Herrero R., Moreno V., and Franceschi S. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 346 (2002) 1105-1112
15. Watts D., Koutsky L., Holmes K., Goldman D., Kuypers J., Kiviat N., and Galloway D. Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study. Am J Obstet Gynecol 178 (1998) 365-372
16. Favre M., Majewski S., De Jesus N., Malejczyk M., Orth G., and Jablonska S. A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J Invest Dermatol 111 (1998) 333-336
17. Bosch F., Lorincz A., Munoz N., Meijer C., and Shah K. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
18. Bosch F., Manos M., Munoz N., Sherman M., Jansen A., Peto J., Schiffman M., Moreno V., Kurman R., and Shah K. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87 (1995) 796-802
19. Walboomers J., Jacobs M., Manos M., Bosch F., Kummer J., Shah K., Snijders P., Peto J., Meijer C., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
20. Munoz N., Bosch F., de Sanjose S., Herrero R., Castellsague X., Shah K., Snijders P., and Meijer C. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
21. Castellsague X., Diaz M., de Sanjose S., Munoz N., Rolando Herrero S., Ashley R., Snijder P., Meijer C., Bosch F., and for International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. The worldwide Human Papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006)
22. Khan M., Castle P., Lorincz A., Wacholder S., Sherman M., Scott D., Rush B., Glass A., and Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97 (2005) 1072-1079
23. Paraskevaidis E., Arbyn M., Sotiriadis A., Diakomanolis E., Martin-Hirsch P., Koliopoulos G., Makrydimas G., Tofoski J., and Roukos D. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 30 (2004) 205-211
24. Munoz N., Bosch F., Castellsague X., Diaz M., de Sanjose S., Hammouda D., Shah K., and Meijer C. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 (2004) 278-285
25. Strickler H., Palefsky J., Shah K., Anastos K., Klein R., Minkoff H., Duerr A., Massad L., Celentano D., Hall C., Fazzari M., Cu-Uvin S., Bacon M., Schuman P., Levine A., Durante A., Gange S., Melnick S., and Burk R. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95 (2003) 1062-1071
26. Clifford G., Smith J., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 (2003) 101-105
27. Clifford G., Smith J., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. BrJ Cancer 88 (2003) 63-73
28. Smith J., Green J., Berrington d., Appleby P., Peto J., Plummer M., Franceschi S., and Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361 (2003) 1159-1167
29. Munoz N., Franceschi S., Bosetti C., Moreno V., Herrero R., Smith J., Shah K., Meijer C., and Bosch F. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359 (2002) 1093-1101
30. Palefsky J., and Holly E. Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr (2003) 41-46